rosoxacin and Urinary-Tract-Infections

rosoxacin has been researched along with Urinary-Tract-Infections* in 2 studies

Other Studies

2 other study(ies) available for rosoxacin and Urinary-Tract-Infections

ArticleYear
Sensitivity of urinary staphylococci to ciprofloxacin and acrosoxacin.
    European journal of clinical microbiology, 1985, Volume: 4, Issue:2

    Topics: 4-Quinolones; Anti-Infective Agents; Ciprofloxacin; Humans; Microbial Sensitivity Tests; Quinolines; Quinolones; Staphylococcus; Urinary Tract Infections

1985
Distribution of quinoline carboxylic acid derivatives in the dog prostate.
    The Prostate, 1983, Volume: 4, Issue:4

    The distribution in the prostate of norfloxacin and rosoxacin, both quinoline carboxylic acid derivatives, was investigated in an experimental dog model. The concentrations in prostatic interstitial fluid (PIF) and prostatic secretion (PS) of both antimicrobials were lower than the corresponding plasma (P) concentrations, as might be expected for acidic compounds. Norfloxacin achieved significantly higher PS/P and PIF/P ratios than rosoxacin following intravenous infusion; there were no differences between the two drugs in the various tissue/plasma ratios. The concentrations of both norfloxacin and rosoxacin in PIF, PS, and urine were in the minimal inhibitory range for most gram-negative pathogens causing bacterial prostatitis and urinary tract infections. Clinical trials may be warranted for both drugs.

    Topics: 4-Quinolones; Administration, Oral; Animals; Anti-Infective Agents; Dogs; Drug Evaluation, Preclinical; Infusions, Parenteral; Male; Nalidixic Acid; Norfloxacin; Prostate; Prostatitis; Quinolines; Quinolones; Time Factors; Tissue Distribution; Urinary Tract Infections

1983